l ' cannot avoid the conundrum of endometriosis.
.' Quite a few of us have taken a stab at its elucidation, and we all know much about its pathology. Considerable attention has been devoted to immunologic and endocrine features . A myriad of publications address medical and surgical treatment. Still, it is arguable whether any real advances have been made over the last several decades. We still lack noninvasive means of diagnosis as well as proven invasive methods. We lack a magic bullet for treatment. Progress seems glacial.
Endometriosis is clearly heritable. In the last century, literally and figuratively, our group conducted the first formal genetic study of the heritability of endometriosis. Studying probands with endometriosis, we found in 1980 that 6% of female siblings older than 18 years and 8% of mothers were similarly affected.! This compared to only 1 % of the patients' husbands' first degree relatives. Our findings were confirmed in Norway,2 the United Kingdom,3 and elsewhere. The 5-8% recurrence risk observed for first-degree relatives strongly suggests polygenic/ multifactorial inheritance, given 25-50% expected for a single mutant gene. The good news is that the number of genes necessary to explain polygenic/ multifactorial inheritance need not be large. 4 If three genes exist, each with two alleles, there are 27 different genotypes (3 n ). If there are three alleles per locus, and two loci, there would be 36 genotypes (6"). Continuous variation can obviously be approximated with only a few genes. Thus, investigators sanguinely sought to detect the (few) genes pivotal for endometriosis. Now that the human genome has been sequenced, the most straightforward approach for finding these genes is quantitative genetic analysis (QTL). This approach is attractive because any region in the genome could code for the pivotal genes. Thus, no a priori hypothesis is necessary. The approach most commonly used is sibling pair analysis. 4 -6 Affected relatives presumably inherit identical copies of any given causative allele, more often than would be expected by chance. Likelihood of identity (of a given allele) by descent is greater for affected siblings than it would be from random expectations for nonaffected first-degree relatives (0.5). IdentifYing the region of interest (descent) is made through common DNA polymorphisms, usually di-or tri-nucleotide repeats. This approach has been diligently pursued by Kennedy,S,6 a co-author on a paper in this issue by Deguchi et aC Yet progress has been disap-pointing. The last publication by a member of the UK (Oxford)-Australian collaboration revealed only "suggestive" linkage for one undisclosed locus. 6 This w as based on 374 sibling pairs scanned for 400 markers approximately 10 cm apart. This was apparently a conclusion similar to that presented by Treloar et al. 8 at the 2002 American Society for Reproductive Medicine meeting. At the 2002 American Society of Human Genetics meeting, the group mentioned existence of two regions of interest. 9 The lack of subsequent published details could be either a comment on necessity to protect patents or evidence of scientific frustration.
A related approach is to study microarrays, either cDNA or tissue. Here one looks not at the gene per se, but rather at the translated gene product. The reasoning is that the causative genes should be underexpressed or overexpressed in endometriotic tissue compared to controls. For example, Taylor et al. 10 compared expression profiles in eutopic endometrium of women with and without endometriosis. The study used Af-fYmetrix Hu95A microarrays (Santa Clara, CAl, a probe set containing more than 12,000 human genes or expressed sequence tags. A total of 91 genes were overexpressed and 115 were underexpressed. Some were predictable, such as gycodelin being underexpressed; others were less predictable. Microarray studies are underway in a host of laboratories, using either cDNA chips or tissue microarrays. The problem with these studies is the opposite of genome-wide linkage studies. Now there is a surfeit of data, so voluminous as to be almost impossible to analyze. In fact, the informatics of cDNA microarray analysis is a field in and of itself Genetically engineered mouse models are seemingly not useful in studying endometriosis. Eventually one must test individual genes and their gene products (proteins). Tissue microarrays may be most pragmatic.!! In this issue of the Journal, perhaps our most diligent QTL advocate has participated in an association study, and with all too familiar results. The association of the slow acetylation allele ofN-acetyltransferase 2 (NAT2) with endometriosis in a French population was not confirmed in either British or Japanese samples. 7 As recounted in multiple reviews by myself! 2 and others,13 many candidate genes have been proposed: ICAM-l, CYP21, MMPs, and my personal favorites, tumor suppressor genes like TP53 and PTEN. Often, a positive association tends to be followed by failure to confirm, or confirmation only with caveats. This has been observed for phase I (Ah receptor, CYPA1, NAT2) and phase II (GST, NAT2) detoxification enzymes.
Why is progress so incremental in elucidating endometriosis? A problem in all association studies, but especially hazardous in endometriosis, is misclassification. Is the case truly affected and is the control really normal? Association studies demand crisp distinction between subjects and controls, ie, proper classification. Absent this, power is diminished and mischief arises. Second, endometriosis is heterogeneous, surely not caused by a single gene. Yet association studies are typically powered under the assumption that a disorder is monogenic (or monolithic). Third, an association is just that, and not necessarily indicative of a causative gene. The association could reflect a nearby gene unsuspected to be causally related. It could reflect a correlative phenomenon controlled by another gene, which may even be located on another chromosome. Other genetic nuances may perturb straightforward interpretation. Are polymorphic markers truly transmitted in Mendelian fashion (random allocation of alleles)? There may exist allelic heterogeneity (different mutations causing the same phenotype) or locus heterogeneity (different loci result in same phenotype). The assumptions of Hardy-Weinberg equilbrium (lack of selection, random mating, lack of migration) are clearly never met. All of these diminish our ability to identifY a causative gene. 4 ,14 Some of the aforementioned pitfalls are within the realm of experimental correction, However, the real culprit in association studies is ethnic (population) stratification. A given allele may be unusually common in a population in which the disease is also common. The "association" thus does not actually reflect causation, but rather convergence of two common yet independent phenomena. For this reason, some investigators (and some journal editors) insist that an association be claimed (published) only when found in more than one ethnic group. Alternatively, raise the bar (P value) for statistical significance before a claim is made. However, this could be overarching because a gene could exist in only one population. Recall the C566T FSHR mutation, a clear cause of ovarian failure yet highly unusual outside Finland. 15 In endometriosis we are left to minimize misclassification, increase sample size, and take into account potential confounders. Most importantly, we are to assume genetic heterogeneity and preserve DNA specimen for post hoc stratification. Naturally, we pine for significant clues from QTL. One final suggestion: Widen the spectrum of candidate genes. Look for surprises, given a decade of pursuing plausible candidate genes that has not yielded notable success. We might have predicted that the development gene HOXA13 was a good candidate for the hand-foot-genital syndrome,16 but who thought that a chaperonine protein was causative for transverse vaginal septum (McKusick-Kaufman Syndrome)?17 Of the 25,000 genes,
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we have not a scintilla of information for 90%. As these genes become identified, many opportunities will exist for novel hypotheses.
